Latest On Supernus Pharmaceuticals, Inc (SUPN):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-10 07:37 EST | News | Supernus Pharmaceuticals, Inc. (SUPN) Q1 2023 Earnings Call Transcript | N/A |  |
| 2023-05-09 18:39 EST | News | Supernus Pharmaceuticals GAAP EPS of $0.29 beats by $0.55, revenue of $153.8M beats by $14.78M | N/A | |
| 2023-05-09 04:36 EST | News | Supernus Pharmaceuticals Q1 2023 Earnings Preview | N/A | |
| 2023-04-04 20:51 EST | News | Supernus Pharmaceuticals pays out $402M senior convertible notes | N/A | |
| 2023-03-01 01:40 EST | News | Supernus Pharmaceuticals reports Q4 results, sees FY 2023 revenue in-line | N/A | |
| 2023-03-01 01:40 EST | News | Supernus Pharmaceuticals, Inc. (SUPN) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-27 20:04 EST | News | Supernus Pharmaceuticals Q4 2022 Earnings Preview | N/A | |
| 2023-02-15 02:54 EST | News | Supernus secures $150M line of credit from UBS Bank USA | N/A | |
| 2023-02-10 18:44 EST | News | Supernus: Earnings Yearnings | N/A | |
| 2022-11-30 06:36 EST | News | Supernus Pharmaceuticals: Shares Could Get Cheap | N/A | |
| 2022-11-08 19:34 EST | News | Supernus Pharmaceuticals GAAP EPS of $0.03 misses by $0.33, revenue of $177.35M beats by $4.87M | N/A | |
| 2022-11-08 19:34 EST | News | Supernus Pharmaceuticals, Inc. (SUPN) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-08 01:06 EST | News | Supernus Pharmaceuticals Q3 2022 Earnings Preview | N/A | |
| 2022-10-10 17:31 EST | News | Supernus stock falls 12.6% after FDA declines to approve Parkinson’s disease treatment | N/A | |
| 2022-09-10 04:18 EST | News | Supernus Pharmaceuticals (SUPN) Investor Presentation - Slideshow | N/A | |
| 2022-08-20 11:47 EST | News | Supernus Pharmaceuticals: Deep Expertise In CNS, Eyes On Qelbree Launch And Parkinson Portfolio | N/A | |
| 2022-08-07 11:02 EST | News | Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-04 17:16 EST | News | Supernus Pharmaceuticals GAAP EPS of $0.14 misses by $0.15, revenue of $170.05M beats by $5.82M | N/A | |
| 2022-08-04 02:17 EST | News | Supernus Pharmaceuticals Q2 2022 Earnings Preview | N/A | |
| 2022-07-29 04:48 EST | News | Supernus: A Work In Progress | N/A | |
| 2022-05-10 14:29 EST | News | Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-09 17:15 EST | News | Supernus Pharmaceuticals GAAP EPS of $0.43 misses by $0.02, revenue of $152.51M beats by $2.04M | N/A | |
| 2022-05-07 08:04 EST | News | Supernus Pharmaceuticals Q1 2022 Earnings Preview | N/A | |
| 2022-05-02 09:21 EST | News | Supernus rises on FDA label expansion of ADHD therapy | N/A | |
| 2022-04-13 23:14 EST | News | Supernus Pharmaceuticals GAAP EPS of $0.04 misses by $0.20, revenue of $159.05M in-line | N/A | |
| 2022-04-04 23:36 EST | News | Supernus Pharmaceuticals drops 2.7% on 2022 guidance | N/A | |
| 2022-03-29 12:05 EST | News | Supernus: New Beginnings | N/A | |
| 2022-03-17 23:24 EST | News | Supernus Pharmaceuticals notifies Nasdaq regarding non-compliance with listing rule | N/A | |
| 2022-03-01 13:25 EST | News | Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-28 00:52 EST | News | Supernus Pharmaceuticals Q4 2021 Earnings Preview | N/A | |
| 2021-12-02 05:34 EST | News | Supernus Pharma resumed Buy at Jefferies citing Adamas acquisition | N/A | |
| 2021-11-27 01:18 EST | News | Jasper more than doubles while M&A headlines weekly healthcare performers | N/A | |
| 2021-11-04 16:57 EST | News | Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-03 19:31 EST | News | Supernus Pharmaceuticals EPS beats by $0.17, beats on revenue; updates full year guidance | N/A | |
| 2021-11-03 19:30 EST | News | Supernus up 10% following 2021 earnings guidance boost, Q3 beat | N/A | |
| 2021-11-02 23:54 EST | News | Supernus Pharmaceuticals Q3 2021 Earnings Preview | N/A | |
| 2021-10-27 03:49 EST | News | Adamas Pharmaceuticals: An Acceptable Buyout At The Perfect Time | N/A | |
| 2021-10-11 18:00 EST | News | Supernus to acquire Adamas in a deal worth up to $850 million | N/A | |
| 2021-10-11 17:59 EST | News | As Supernus acquires Adamas, other Parkinson's players mixed on the day | N/A | |
| 2021-09-03 02:57 EST | News | FDA accepts for review Supernus' Qelbree sNDA for ADHD in adults | N/A | |
| 2021-08-26 01:08 EST | News | Supernus: Well Prepared For Upcoming Challenges | N/A | |
| 2021-08-05 13:54 EST | News | Supernus Pharmaceuticals EPS beats by $0.23, beats on revenue | N/A | |
| 2021-08-05 13:53 EST | News | Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-03 19:03 EST | News | Supernus Pharmaceuticals Q2 2021 Earnings Preview | N/A | |
| 2021-07-30 21:28 EST | News | Supernus Pharma appoints Opgen executive as new CFO | N/A | |
| 2021-07-22 02:11 EST | News | Supernus Pharma inks supply agreement with Bachem for key ingredient in ADHD drug | N/A | |
| 2021-05-05 23:52 EST | News | Supernus Pharmaceuticals EPS misses by $0.11, beats on revenue; reaffirms guidance | N/A | |
| 2021-05-05 23:51 EST | News | Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2021-05-05 03:39 EST | News | Supernus Pharmaceuticals Q1 2021 Earnings Preview | N/A | |
| 2021-04-13 20:31 EST | News | IRhythm extends losses as more downgrades pile up, Aphria cut to neutral after earnings miss; and more in today’s analyst action | N/A | |
About Supernus Pharmaceuticals, Inc (SUPN):
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. Its commercial products include Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset epilepsy seizures in adults and children between 6 to 17 years of age. The company's commercial products also comprise APOKYN, a product indicated for the acute intermittent treatment of hypomobility or off episodes in patients with advanced Parkinson's Disease (PD); XADAGO, a product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD experiencing off episodes; and MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and sialorrhea in adults. In addition, its product candidates include SPN-812, which has completed Phase III clinical trials that is used for the treatment of attention deficit hyperactivity disorder (ADHD); SPN-830, a late-stage drug/device combination product candidate for the prevention of off episodes in PD; SPN-817, a novel product candidate in Phase I clinical trials for the treatment of severe epilepsy; and SPN-820, a novel product candidate in Phase I clinical trials for treatment resistant depression. The company markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. It has a development and option agreement with Navitor Pharmaceuticals, Inc. to conduct a Phase II clinical program for NV-5138 in treatment-resistant depression. The company was founded in 2005 and is headquartered in Rockville, Maryland.
General
- Name Supernus Pharmaceuticals, Inc
- Symbol SUPN
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 563
- Fiscal Year EndDecember
- IPO Date2012-05-01
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.supernus.com
View More
Valuation
- Trailing PE 11.12
- Forward PE 20.16
- Price/Sales (Trailing 12 Mt.) 2.76
- Price/Book (Most Recent Quarter) 1.9
- Enterprise Value Revenue 2.66
- Enterprise Value EBITDA 6.58
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $1.02
- Next Year EPS Estimate $1.24
- Next Quarter EPS Estimate $0.40
- Profit Margin 24%
- Operating Margin 36%
- Return on Assets 9%
- Return on Equity 19%
- Revenue 520.4 million
- Earnings Per Share $2.36
- Revenue Per Share $9.89
- Gross Profit 467.94 million
- Quarterly Earnings Growth 42.9%
View More
Highlights
- Market Capitalization 1.39 billion
- EBITDA 206.24 million
- PE Ratio 369.82
- PEG Ratio 1.47
- Analyst Target Price $30.75
- Book Value Per Share $14.09
View More
Share Statistics
- Shares Outstanding 52.92 million
- Shares Float 47.91 million
- % Held by Insiders 361%
- % Held by Institutions 101.46%
- Shares Short 7.47 million
- Shares Short Prior Month 7.15 million
- Short Ratio 14.42
- Short % of Float 21%
- Short % of Shares Outstanding 14%
View More
Technicals
- Beta 1.29
- 52 Week High $31.99
- 52 Week Low $15.58
- 50 Day Moving Average 28.34
- 200 Day Moving Average 24.03
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Supernus Pharmaceuticals, Inc (SUPN) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Supernus Pharmaceuticals, Inc (SUPN) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $N/A | $0.57 | $0.49 | 16.33% |
| 2020-09-30 | 2020-11-03 | $155.14 million | $0.74 | $0.27 | 170.76% |
| 2020-06-30 | 2020-08-17 | $126.73 million | $0.65 | $0.42 | 54.76% |
| 2020-03-31 | 2020-05-05 | $N/A | $0.40 | $0.26 | 53.85% |
| 2019-12-31 | 2020-02-25 | $100.45 million | $0.62 | $0.59 | 5.8% |
| 2019-09-30 | 2019-11-05 | $102.14 million | $0.54 | $0.59 | -8.47% |
| 2019-06-30 | 2019-08-06 | $104.7 million | $0.61 | $0.60 | 1.24% |
| 2019-03-31 | 2019-05-07 | $85.47 million | $0.34 | $0.47 | -26.88% |
| 2018-12-31 | 2019-02-26 | $115.93 million | $0.48 | $0.29 | 67.19% |
| 2018-09-30 | 2018-11-06 | $103 million | $0.52 | $0.42 | 22.93% |
| 2018-06-30 | 2018-08-07 | $99.54 million | $0.57 | $0.45 | 26.67% |
| 2018-03-31 | 2018-05-08 | $90.43 million | $0.49 | $0.32 | 51.94% |
| 2017-12-31 | 2018-02-27 | $88.44 million | $0.26 | $0.28 | -7.6% |
| 2017-09-30 | 2017-11-06 | $80.4 million | $0.30 | $0.28 | 6.71% |
| 2017-06-30 | 2017-08-02 | $75.83 million | $0.33 | $0.24 | 36.5% |
| 2017-03-31 | 2017-05-09 | $57.58 million | $0.19 | $0.25 | -24% |
| 2016-12-31 | 2017-01-20 | $62.37 million | $0.37 | $0.34 | 7.19% |
| 2016-09-30 | 2016-09-30 | $56.81 million | $1.18 | $0.34 | 247.06% |
| 2016-06-30 | 2016-08-02 | $51.63 million | $0.18 | $0.13 | 36.67% |
| 2016-03-31 | 2016-05-04 | $44.19 million | $0.10 | $0.09 | 13.8% |
| 2015-12-31 | 2016-03-02 | $43.69 million | $0.14 | $0.06 | 128.83% |
| 2015-09-30 | 2015-11-03 | $39.36 million | $0.08 | $0.02 | 300% |
| 2015-06-30 | 2015-08-04 | $35.68 million | $0.03 | $0.02 | 50% |
| 2015-03-31 | 2015-05-05 | $28.74 million | $0.02 | -$0.01 | 300% |
| 2014-12-31 | 2015-03-10 | $31.24 million | $0.10 | -$0.12 | 183.33% |
| 2014-09-30 | 2014-11-11 | $52.49 million | $0.39 | $0.36 | 8.33% |
| 2014-06-30 | 2014-08-11 | $29.68 million | $0.08 | -$0.15 | 153.33% |
| 2014-03-31 | 2014-05-12 | $9.08 million | -$0.35 | -$0.41 | 14.63% |
| 2013-12-31 | 2014-03-12 | $10.34 million | -$0.39 | -$0.55 | 29.09% |
| 2013-09-30 | 2013-11-12 | $1.26 million | -$0.64 | -$0.67 | 4.48% |
| 2013-06-30 | 2013-08-13 | $281000 | -$0.57 | -$0.65 | 12.31% |
| 2013-03-31 | 2013-05-13 | $147000 | -$0.60 | -$0.71 | 15.49% |
| 2012-12-31 | 2013-03-14 | $1.09 million | -$0.51 | -$0.71 | 28.17% |
| 2012-09-30 | 2012-11-07 | $92000 | -$0.55 | -$0.62 | 11.29% |
| 2012-06-30 | 2012-08-10 | $91000 | -$0.61 | -$0.48 | -27.08% |
| 2012-03-31 | 2012-06-07 | $208000 | -$0.42 |
Supernus Pharmaceuticals, Inc (SUPN) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Supernus Pharmaceuticals, Inc (SUPN) Chart:
Supernus Pharmaceuticals, Inc (SUPN) News:
Below you will find a list of latest news for Supernus Pharmaceuticals, Inc (SUPN) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Supernus Pharmaceuticals, Inc (SUPN) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-20 | 15 | 0 | CALL | 0 | 0 | 85.42 | TRUE | 0 | 0 |
| 2024-12-20 | 20 | 12.18 | CALL | 0 | 12 | 77.33 | TRUE | 0 | 0 |
| 2024-12-20 | 22 | 0 | CALL | 0 | 0 | 58.82 | TRUE | 0 | 0 |
| 2024-12-20 | 23 | 0 | CALL | 0 | 0 | 61.79 | TRUE | 0 | 0 |
| 2024-12-20 | 24 | 0 | CALL | 0 | 0 | 57.35 | TRUE | 0 | 0 |
| 2024-12-20 | 25 | 0 | CALL | 0 | 0 | 52.84 | TRUE | 0 | 0 |
| 2024-12-20 | 26 | 0 | CALL | 0 | 0 | 55.3 | TRUE | 0 | 0 |
| 2024-12-20 | 27 | 0 | CALL | 0 | 0 | 46.2 | TRUE | 0 | 0 |
| 2024-12-20 | 28 | 0 | CALL | 0 | 0 | 50.23 | TRUE | 0 | 0 |
| 2024-12-20 | 29 | 7.5 | CALL | 0 | 2 | 53.3 | TRUE | 0 | 0 |
| 2024-12-20 | 30 | 4.2 | CALL | 0 | 5 | 43.41 | TRUE | 0 | 0 |
| 2024-12-20 | 31 | 2.25 | CALL | 0 | 3 | 45.49 | TRUE | 0 | 0 |
| 2024-12-20 | 32 | 2.3 | CALL | 0 | 2 | 44.67 | TRUE | 0 | 0 |
| 2024-12-20 | 33 | 2.15 | CALL | 0 | 16 | 47.93 | FALSE | 0 | 0 |
| 2024-12-20 | 34 | 3.6 | CALL | 0 | 28 | 46.08 | FALSE | 0 | 0 |
| 2024-12-20 | 35 | 1.25 | CALL | 0 | 41 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 36 | 1.2 | CALL | 1 | 12 | 41.61 | FALSE | 1.2 | 0 |
| 2024-12-20 | 37 | 3.21 | CALL | 0 | 38 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 38 | 2.54 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 40 | 1.6 | CALL | 0 | 30 | 43.39 | FALSE | 0 | 0 |
| 2024-12-20 | 45 | 0.8 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 50 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 15 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 20 | 0.55 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 22 | 1.3 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 23 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 24 | 2 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 25 | 0.7 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 26 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 27 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 28 | 1.2 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 29 | 1.15 | PUT | 0 | 1 | 39.64 | FALSE | 0 | 0 |
| 2024-12-20 | 30 | 5.05 | PUT | 0 | 2 | 55.91 | FALSE | 0 | 0 |
| 2024-12-20 | 31 | 1.91 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 32 | 0 | PUT | 0 | 0 | 52.54 | TRUE | 0 | 0 |
| 2024-12-20 | 33 | 0 | PUT | 0 | 0 | 45.29 | TRUE | 0 | 0 |
| 2024-12-20 | 34 | 3.5 | PUT | 0 | 5 | 50.22 | TRUE | 0 | 0 |
| 2024-12-20 | 35 | 3.6 | PUT | 0 | 5 | 42.69 | TRUE | 0 | 0 |
| 2024-12-20 | 36 | 4.1 | PUT | 0 | 24 | 49.25 | TRUE | 0 | 0 |
| 2024-12-20 | 37 | 0 | PUT | 0 | 0 | 52.22 | TRUE | 0 | 0 |
| 2024-12-20 | 38 | 0 | PUT | 0 | 0 | 55.73 | TRUE | 0 | 0 |
| 2024-12-20 | 40 | 0 | PUT | 0 | 0 | 55.46 | TRUE | 0 | 0 |
| 2024-12-20 | 45 | 0 | PUT | 0 | 0 | 92.57 | TRUE | 0 | 0 |
| 2024-12-20 | 50 | 0 | PUT | 0 | 0 | 103.28 | TRUE | 0 | 0 |
| 2025-03-21 | 15 | 0 | CALL | 0 | 0 | 76.07 | TRUE | 0 | 0 |
| 2025-03-21 | 20 | 0 | CALL | 0 | 0 | 53.15 | TRUE | 0 | 0 |
| 2025-03-21 | 21 | 0 | CALL | 0 | 0 | 58.73 | TRUE | 0 | 0 |
| 2025-03-21 | 22 | 14.77 | CALL | 0 | 100 | 54.72 | TRUE | 0 | 0 |
| 2025-03-21 | 23 | 0 | CALL | 0 | 0 | 51.94 | TRUE | 0 | 0 |
| 2025-03-21 | 24 | 0 | CALL | 0 | 0 | 50.08 | TRUE | 0 | 0 |
| 2025-03-21 | 25 | 0 | CALL | 0 | 0 | 47.93 | TRUE | 0 | 0 |
| 2025-03-21 | 26 | 0 | CALL | 0 | 0 | 47.24 | TRUE | 0 | 0 |
| 2025-03-21 | 27 | 0 | CALL | 0 | 0 | 44.51 | TRUE | 0 | 0 |
| 2025-03-21 | 28 | 0 | CALL | 0 | 0 | 44.48 | TRUE | 0 | 0 |
| 2025-03-21 | 29 | 0 | CALL | 0 | 0 | 43.21 | TRUE | 0 | 0 |
| 2025-03-21 | 30 | 5.3 | CALL | 0 | 50 | 43.11 | TRUE | 0 | 0 |
| 2025-03-21 | 31 | 0 | CALL | 0 | 0 | 43.4 | TRUE | 0 | 0 |
| 2025-03-21 | 32 | 0 | CALL | 0 | 0 | 44.05 | TRUE | 0 | 0 |
| 2025-03-21 | 33 | 3 | CALL | 0 | 5 | 52.59 | FALSE | 0 | 0 |
| 2025-03-21 | 34 | 5 | CALL | 0 | 3 | 51.09 | FALSE | 0 | 0 |
| 2025-03-21 | 35 | 2.6 | CALL | 0 | 7 | 49.53 | FALSE | 0 | 0 |
| 2025-03-21 | 36 | 2.05 | CALL | 0 | 6 | 49.34 | FALSE | 0 | 0 |
| 2025-03-21 | 37 | 2.7 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 38 | 2.79 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 39 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 40 | 1.08 | CALL | 0 | 57 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 45 | 1.2 | CALL | 0 | 3 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 50 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 15 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 20 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 21 | 0.8 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 22 | 0.85 | PUT | 0 | 3 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 23 | 0.7 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 24 | 1.85 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 25 | 1.2 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 26 | 1.2 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 27 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 28 | 2.2 | PUT | 0 | 6 | 0 | FALSE | 0 | 0 |
| 2025-03-21 | 29 | 0 | PUT | 0 | 0 | 45.13 | FALSE | 0 | 0 |
| 2025-03-21 | 30 | 2.1 | PUT | 0 | 10 | 48.53 | FALSE | 0 | 0 |
| 2025-03-21 | 31 | 0 | PUT | 0 | 0 | 51.47 | FALSE | 0 | 0 |
| 2025-03-21 | 32 | 0 | PUT | 0 | 0 | 52.05 | TRUE | 0 | 0 |
| 2025-03-21 | 33 | 0 | PUT | 0 | 0 | 50.17 | TRUE | 0 | 0 |
| 2025-03-21 | 34 | 0 | PUT | 0 | 0 | 52.54 | TRUE | 0 | 0 |
| 2025-03-21 | 35 | 0 | PUT | 0 | 0 | 50.48 | TRUE | 0 | 0 |
| 2025-03-21 | 36 | 0 | PUT | 0 | 0 | 45.09 | TRUE | 0 | 0 |
| 2025-03-21 | 37 | 0 | PUT | 0 | 0 | 41.42 | TRUE | 0 | 0 |
| 2025-03-21 | 38 | 0 | PUT | 0 | 0 | 46.57 | TRUE | 0 | 0 |
| 2025-03-21 | 39 | 0 | PUT | 0 | 0 | 43.89 | TRUE | 0 | 0 |
| 2025-03-21 | 40 | 0 | PUT | 0 | 0 | 48.1 | TRUE | 0 | 0 |
| 2025-03-21 | 45 | 0 | PUT | 0 | 0 | 41.16 | TRUE | 0 | 0 |
| 2025-03-21 | 50 | 0 | PUT | 0 | 0 | 52.95 | TRUE | 0 | 0 |
Latest SUPN Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $26.54 |
| Jun 13, 2022 7:59 PM EST | 78 | $26.52 |
| Jun 13, 2022 7:59 PM EST | 12 | $26.53 |
| Jun 13, 2022 7:59 PM EST | 100 | $26.52 |
| Jun 13, 2022 7:59 PM EST | 113 | $26.54 |
Supernus Pharmaceuticals, Inc (SUPN) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000044/0001356576-20-000044-index.htm |
| 2018-09-21 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1356576/000000000018029835/0000000000-18-029835-index.htm |
| 2018-11-02 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1356576/000000000018034262/0000000000-18-034262-index.htm |
| 2018-12-07 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1356576/000000000018037479/0000000000-18-037479-index.htm |
| 2019-07-17 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1356576/000000000019011207/0000000000-19-011207-index.htm |
| 2019-08-07 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1356576/000000000019012145/0000000000-19-012145-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1356576/000021545719007287/0000215457-19-007287-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1356576/000083423720008681/0000834237-20-008681-index.htm |
| 2020-03-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1356576/000091957420002390/0000919574-20-002390-index.htm |
| 2019-01-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1356576/000093247119001355/0000932471-19-001355-index.htm |
| 2019-03-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1356576/000104746919000828/0001047469-19-000828-index.htm |
| 2019-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1356576/000104746919002684/0001047469-19-002684-index.htm |
| 2018-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1356576/000110465918032082/0001104659-18-032082-index.htm |
| 2018-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918032502/0001104659-18-032502-index.htm |
| 2018-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm |
| 2018-05-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm |
| 2018-05-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918034093/0001104659-18-034093-index.htm |
| 2018-05-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918037201/0001104659-18-037201-index.htm |
| 2018-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918039860/0001104659-18-039860-index.htm |
| 2018-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm |
| 2018-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465918041853/0001104659-18-041853-index.htm |
| 2018-06-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm |
| 2018-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918043589/0001104659-18-043589-index.htm |
| 2018-07-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465918043595/0001104659-18-043595-index.htm |
| 2018-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465918043597/0001104659-18-043597-index.htm |
| 2018-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm |
| 2018-07-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918047769/0001104659-18-047769-index.htm |
| 2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918050207/0001104659-18-050207-index.htm |
| 2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1356576/000110465918050920/0001104659-18-050920-index.htm |
| 2018-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918055089/0001104659-18-055089-index.htm |
| 2018-09-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918055660/0001104659-18-055660-index.htm |
| 2018-09-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918057416/0001104659-18-057416-index.htm |
| 2018-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918057845/0001104659-18-057845-index.htm |
| 2018-10-05 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1356576/000110465918060747/0001104659-18-060747-index.htm |
| 2018-10-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918063964/0001104659-18-063964-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918066367/0001104659-18-066367-index.htm |
| 2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918066998/0001104659-18-066998-index.htm |
| 2018-11-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1356576/000110465918067217/0001104659-18-067217-index.htm |
| 2018-11-16 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1356576/000110465918069011/0001104659-18-069011-index.htm |
| 2018-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918072139/0001104659-18-072139-index.htm |
| 2018-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918073844/0001104659-18-073844-index.htm |
| 2018-12-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465918074466/0001104659-18-074466-index.htm |
| 2019-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919002327/0001104659-19-002327-index.htm |
| 2019-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465919005844/0001104659-19-005844-index.htm |
| 2019-02-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465919007979/0001104659-19-007979-index.htm |
| 2019-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465919010743/0001104659-19-010743-index.htm |
| 2019-02-26 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919010791/0001104659-19-010791-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919010794/0001104659-19-010794-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919010795/0001104659-19-010795-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919010796/0001104659-19-010796-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919010797/0001104659-19-010797-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919010798/0001104659-19-010798-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919010799/0001104659-19-010799-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919010800/0001104659-19-010800-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919010801/0001104659-19-010801-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919010802/0001104659-19-010802-index.htm |
| 2019-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919011559/0001104659-19-011559-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919012547/0001104659-19-012547-index.htm |
| 2019-03-04 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919012549/0001104659-19-012549-index.htm |
| 2019-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465919013142/0001104659-19-013142-index.htm |
| 2019-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919016356/0001104659-19-016356-index.htm |
| 2019-03-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465919018296/0001104659-19-018296-index.htm |
| 2019-04-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465919019961/0001104659-19-019961-index.htm |
| 2019-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465919023424/0001104659-19-023424-index.htm |
| 2019-04-25 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1356576/000110465919023500/0001104659-19-023500-index.htm |
| 2019-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919024504/0001104659-19-024504-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465919027555/0001104659-19-027555-index.htm |
| 2019-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1356576/000110465919028593/0001104659-19-028593-index.htm |
| 2019-05-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465919033130/0001104659-19-033130-index.htm |
| 2019-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919037264/0001104659-19-037264-index.htm |
| 2019-07-31 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1356576/000110465919043062/0001104659-19-043062-index.htm |
| 2019-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919043393/0001104659-19-043393-index.htm |
| 2019-08-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919047536/0001104659-19-047536-index.htm |
| 2019-12-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465919076466/0001104659-19-076466-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1356576/000110465920017388/0001104659-20-017388-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024846/0001104659-20-024846-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024847/0001104659-20-024847-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024848/0001104659-20-024848-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024849/0001104659-20-024849-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024850/0001104659-20-024850-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024851/0001104659-20-024851-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024852/0001104659-20-024852-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024853/0001104659-20-024853-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024891/0001104659-20-024891-index.htm |
| 2020-02-25 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024913/0001104659-20-024913-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024915/0001104659-20-024915-index.htm |
| 2020-02-25 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024919/0001104659-20-024919-index.htm |
| 2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024920/0001104659-20-024920-index.htm |
| 2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000110465920026188/0001104659-20-026188-index.htm |
| 2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920037450/0001104659-20-037450-index.htm |
| 2020-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1356576/000110465920050721/0001104659-20-050721-index.htm |
| 2020-04-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1356576/000110465920050722/0001104659-20-050722-index.htm |
| 2020-05-04 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1356576/000110465920056047/0001104659-20-056047-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920059729/0001104659-20-059729-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920064386/0001104659-20-064386-index.htm |
| 2020-06-26 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1356576/000110465920077403/0001104659-20-077403-index.htm |
| 2020-07-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920083086/0001104659-20-083086-index.htm |
| 2020-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920083754/0001104659-20-083754-index.htm |
| 2020-07-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920087366/0001104659-20-087366-index.htm |
| 2020-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920100179/0001104659-20-100179-index.htm |
| 2020-10-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920114365/0001104659-20-114365-index.htm |
| 2020-10-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920114367/0001104659-20-114367-index.htm |
| 2020-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920115378/0001104659-20-115378-index.htm |
| 2020-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1356576/000110465920122611/0001104659-20-122611-index.htm |
| 2019-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657619000010/0001356576-19-000010-index.htm |
| 2019-07-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657619000015/0001356576-19-000015-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657619000019/0001356576-19-000019-index.htm |
| 2019-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1356576/000135657619000025/0001356576-19-000025-index.htm |
| 2019-08-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657619000030/0001356576-19-000030-index.htm |
| 2019-09-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657619000033/0001356576-19-000033-index.htm |
| 2019-10-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657619000041/0001356576-19-000041-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657619000043/0001356576-19-000043-index.htm |
| 2019-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1356576/000135657619000045/0001356576-19-000045-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657619000047/0001356576-19-000047-index.htm |
| 2019-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657619000049/0001356576-19-000049-index.htm |
| 2020-01-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000002/0001356576-20-000002-index.htm |
| 2020-01-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000004/0001356576-20-000004-index.htm |
| 2020-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000006/0001356576-20-000006-index.htm |
| 2020-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000010/0001356576-20-000010-index.htm |
| 2020-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000015/0001356576-20-000015-index.htm |
| 2020-04-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000018/0001356576-20-000018-index.htm |
| 2020-04-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000020/0001356576-20-000020-index.htm |
| 2020-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000023/0001356576-20-000023-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000025/0001356576-20-000025-index.htm |
| 2020-05-12 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000029/0001356576-20-000029-index.htm |
| 2020-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000031/0001356576-20-000031-index.htm |
| 2020-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000033/0001356576-20-000033-index.htm |
| 2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000035/0001356576-20-000035-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000037/0001356576-20-000037-index.htm |
| 2020-06-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000041/0001356576-20-000041-index.htm |
| 2020-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000044/0001356576-20-000044-index.htm |
| 2020-08-11 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000048/0001356576-20-000048-index.htm |
| 2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000050/0001356576-20-000050-index.htm |
| 2020-08-17 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000054/0001356576-20-000054-index.htm |
| 2020-08-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000056/0001356576-20-000056-index.htm |
| 2020-08-24 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000059/0001356576-20-000059-index.htm |
| 2020-09-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000062/0001356576-20-000062-index.htm |
| 2020-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000064/0001356576-20-000064-index.htm |
| 2020-09-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000066/0001356576-20-000066-index.htm |
| 2020-10-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000068/0001356576-20-000068-index.htm |
| 2020-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000070/0001356576-20-000070-index.htm |
| 2020-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000072/0001356576-20-000072-index.htm |
| 2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1356576/000135657620000076/0001356576-20-000076-index.htm |
| 2018-11-30 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1356576/999999999718009168/9999999997-18-009168-index.htm |
Supernus Pharmaceuticals, Inc (SUPN) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Supernus Pharmaceuticals, Inc (SUPN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 361%Institutional Ownership: 10146%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-06-29 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sell | 4,393.00 | 59.90 | 263,153.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm |
| 2020-02-21 | Frederick M. Hudson | Director | Buy | 5,211.00 | 23.99 | 125,011.89 | 10,211.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024852/0001104659-20-024852-index.htm |
| 2018-05-10 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sell | 20,000.00 | 49.88 | 997,544.00 | 12,500.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm |
| 2018-05-11 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sell | 20,000.00 | 52.03 | 1,040,558.00 | 12,500.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm |
| 2018-06-21 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Buy | 7,205.00 | 9.13 | 65,781.65 | 14,705.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918041853/0001104659-18-041853-index.htm |
| 2018-05-15 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Buy | 7,500.00 | 9.13 | 68,475.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm |
| 2020-07-13 | Frederick M. Hudson | Director | Sell | 920.00 | 24.44 | 22,484.80 | 18,041.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920083754/0001104659-20-083754-index.htm |
| 2018-05-11 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Buy | 10,882.00 | 9.24 | 100,549.68 | 18,382.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm |
| 2020-07-13 | Frederick M. Hudson | Director | Buy | 8,750.00 | 2.56 | 22,400.00 | 18,961.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920083754/0001104659-20-083754-index.htm |
| 2018-06-18 | Stefan K.F. Schwabe | Executive VP R&D, CMO | Sell | 60,000.00 | 54.39 | 3,263,352.00 | 1,967.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm |
| 2018-06-18 | Stefan K.F. Schwabe | Executive VP R&D, CMO | Buy | 20,000.00 | 7.90 | 158,000.00 | 21,967.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm |
| 2018-05-11 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Buy | 11,250.00 | 9.24 | 103,950.00 | 23,750.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm |
| 2018-08-20 | JOHN M SIEBERT | Director | Buy | 8,722.00 | 7.90 | 68,903.80 | 28,285.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465919012547/0001104659-19-012547-index.htm |
| 2018-05-10 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Buy | 20,000.00 | 7.90 | 158,000.00 | 32,500.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm |
| 2018-05-11 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Buy | 20,000.00 | 7.90 | 158,000.00 | 32,500.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm |
| 2018-08-20 | JOHN M SIEBERT | Director | Buy | 7,457.00 | 9.24 | 68,902.68 | 35,742.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465919012547/0001104659-19-012547-index.htm |
| 2018-06-28 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sell | 3,402.00 | 59.94 | 203,899.21 | 4,393.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm |
| 2020-10-15 | GREGORY S PATRICK | Sr. VP, CFO | Sell | 15,000.00 | 20.03 | 300,507.00 | 44,463.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920115378/0001104659-20-115378-index.htm |
| 2020-11-05 | GREGORY S PATRICK | Sr. VP, CFO | Sell | 5,000.00 | 23.00 | 115,000.00 | 44,463.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920122611/0001104659-20-122611-index.htm |
| 2019-04-25 | JOHN M SIEBERT | Director | Buy | 10,000.00 | 9.13 | 91,300.00 | 45,742.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465919024504/0001104659-19-024504-index.htm |
| 2020-05-08 | GREGORY S PATRICK | Sr VP, Chief Financial Officer | Sell | 15,000.00 | 23.14 | 347,034.00 | 46,057.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920059729/0001104659-20-059729-index.htm |
| 2020-05-20 | GREGORY S PATRICK | Sr.VP, Chief Financial Officer | Sell | 15,000.00 | 25.03 | 375,379.50 | 46,057.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920064386/0001104659-20-064386-index.htm |
| 2019-08-23 | Jack A. Khattar | President, CEO | Buy | 7,200.00 | 26.39 | 189,982.08 | 465,141.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465919047536/0001104659-19-047536-index.htm |
| 2019-02-27 | GREGORY S PATRICK | Sr VP, Chief Financial Officer | Sell | 20,000.00 | 41.53 | 830,650.00 | 47,896.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465919011559/0001104659-19-011559-index.htm |
| 2020-07-10 | Jack A. Khattar | President, CEO | Buy | 15,625.00 | 490,841.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920083086/0001104659-20-083086-index.htm | ||
| 2020-11-05 | GREGORY S PATRICK | Sr. VP, CFO | Buy | 5,000.00 | 12.98 | 64,900.00 | 49,463.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920122611/0001104659-20-122611-index.htm |
| 2020-07-27 | Jack A. Khattar | President, CEO | Buy | 15,625.00 | 506,466.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920087366/0001104659-20-087366-index.htm | ||
| 2020-02-21 | Carrolee Barlow | Director | Buy | 5,211.00 | 23.99 | 125,011.89 | 5,211.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024853/0001104659-20-024853-index.htm |
| 2020-02-21 | GEORGES GEMAYEL | Director | Buy | 5,211.00 | 23.99 | 125,011.89 | 5,211.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024851/0001104659-20-024851-index.htm |
| 2019-06-20 | JOHN M SIEBERT | Director | Buy | 10,000.00 | 9.13 | 91,300.00 | 55,742.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465919037264/0001104659-19-037264-index.htm |
| 2018-07-02 | GREGORY S PATRICK | VP, Chief Financial Officer | Sell | 35,000.00 | 56.63 | 1,981,913.50 | 55,975.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm |
| 2020-10-15 | GREGORY S PATRICK | Sr. VP, CFO | Buy | 15,000.00 | 12.98 | 194,700.00 | 59,463.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920115378/0001104659-20-115378-index.htm |
| 2020-02-21 | JOHN M SIEBERT | Director | Buy | 5,211.00 | 23.99 | 125,011.89 | 60,953.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024846/0001104659-20-024846-index.htm |
| 2020-05-08 | GREGORY S PATRICK | Sr VP, Chief Financial Officer | Buy | 15,000.00 | 9.13 | 136,950.00 | 61,057.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920059729/0001104659-20-059729-index.htm |
| 2020-05-20 | GREGORY S PATRICK | Sr.VP, Chief Financial Officer | Buy | 15,000.00 | 12.98 | 194,700.00 | 61,057.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920064386/0001104659-20-064386-index.htm |
| 2018-06-18 | Stefan K.F. Schwabe | Executive VP R&D, CMO | Buy | 40,000.00 | 9.24 | 369,600.00 | 61,967.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918041086/0001104659-18-041086-index.htm |
| 2019-02-27 | GREGORY S PATRICK | Sr VP, Chief Financial Officer | Buy | 20,000.00 | 9.13 | 182,600.00 | 67,896.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465919011559/0001104659-19-011559-index.htm |
| 2018-05-11 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sell | 16,250.00 | 55.23 | 897,542.75 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm |
| 2018-05-11 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sell | 10,882.00 | 57.90 | 630,067.80 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918032900/0001104659-18-032900-index.htm |
| 2018-05-15 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sell | 368.00 | 57.93 | 21,316.62 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm |
| 2018-06-21 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Sell | 7,205.00 | 60.00 | 432,323.06 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918041853/0001104659-18-041853-index.htm |
| 2018-07-02 | GREGORY S PATRICK | VP, Chief Financial Officer | Buy | 20,000.00 | 9.24 | 184,800.00 | 75,975.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm |
| 2018-06-28 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Buy | 295.00 | 9.13 | 2,693.35 | 7,795.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918043279/0001104659-18-043279-index.htm |
| 2018-05-15 | Padmanabh P. Bhatt | Sr. VP of IP, CSO | Buy | 368.00 | 9.24 | 3,400.32 | 7,868.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918033849/0001104659-18-033849-index.htm |
| 2018-07-02 | GREGORY S PATRICK | VP, Chief Financial Officer | Buy | 15,000.00 | 9.13 | 136,950.00 | 90,975.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465918043825/0001104659-18-043825-index.htm |
| 2020-02-21 | CHARLES W III NEWHALL | Director | Buy | 5,211.00 | 23.99 | 125,011.89 | 97,509.00 | https://www.sec.gov/Archives/edgar/data/1356576/000110465920024891/0001104659-20-024891-index.htm |